PRLD insider buying
Every open-market purchase of Prelude Therapeutics Inc (PRLD) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$25M
Insiders buying (12m)2
Purchases on record2
Last purchase filedApr 23, 2026
In the last 12 months, 2 insiders of Prelude Therapeutics Inc bought $25M of PRLD stock on the open market in 2 reported purchases. The most recent was filed on Apr 23, 2026: Bonita David P (Director, 10% Owner) bought 2,815,315 shares at $4.44, worth $12.50M.
Get the next PRLD insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on Telegram